Sponsor-CRO practices that facilitate the creation of a high-quality pathology report: a pharmaceutical sponsor's perspective
Toxicol Pathol
.
2011 Oct;39(6):1013-6.
doi: 10.1177/0192623311419525.
Authors
Armando R Irizarry Rovira
1
,
George L Foley
,
Frances A Clemo
Affiliation
1
Department of Pathology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46225, USA.
[email protected]
PMID:
21971935
DOI:
10.1177/0192623311419525
No abstract available
MeSH terms
Contract Services*
Drug Evaluation, Preclinical
Drug Industry
Pathology*
Peer Review*
Research
Research Report / standards*
Toxicology*